Wolf Group Capital Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.23M Sell
13,678
-3,154
-19% -$294K 0.41% 76
2024
Q4
$1.94M Hold
16,832
0.94% 38
2024
Q3
$1.94M Sell
16,832
-1,338
-7% -$159K 0.92% 39
2024
Q2
$2.25M Buy
18,170
+1,338
+8% +$172K 0.89% 37
2024
Q1
$1.94M Hold
16,832
0.92% 39
2023
Q4
$1.94M Buy
16,832
+267
+2% +$27.7K 0.92% 39
2023
Q3
$1.71M Sell
16,565
-267
-2% -$28.8K 0.81% 43
2023
Q2
$1.87M Buy
+16,832
New +$1.91M 0.93% 35

Other funds holding MRK

Wolf Group Capital Advisors's MRK Position: Q1 2025 in Review

Wolf Group Capital Advisors reduced its Merck (MRK) stake by 19% in Q1 2025, selling an estimated $294K and leaving 13,678 shares worth $1.23M. The position accounts for 0.41% of the portfolio, ranked #76.

Wolf Group Capital Advisors first reported a position in MRK in Q2 2023 and has held it in 8 quarters since. The position peaked at $2.25M in Q2 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Wolf Group Capital Advisors held 13,678 shares of Merck worth $1.23M as of Q1 2025.
  • Wolf Group Capital Advisors sold 3,154 Merck shares in Q1 2025, an estimated $294K.
  • Merck made up 0.41% of Wolf Group Capital Advisors's portfolio in Q1 2025, its #76 holding.
  • Wolf Group Capital Advisors first reported a position in Merck in Q2 2023 and has held it in 8 quarters since.
  • Wolf Group Capital Advisors's Merck position peaked at $2.25M in Q2 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Wolf Group Capital Advisors's 13F filing for Q1 2025, filed 18 Apr 2025.